Bayer Czech Republic made a net profit of CZK CZK 123 mil under revenues of CZK 4,277 mil in 2015, up 15.4% and 5.49%, respectively, when compared to the last year.
This translates into a net margin of 2.89%. Historically, the firm’s net margin reached an all time high of 10.8% in 2003 and an all time low of -1.86% in 2007. The average net margin in the last five years amounted to 3.17%.
On the operating level, EBITDA margin reached 3.83% and EBIT amounted to 3.93% of sales in 2015.
As far as Bayer Czech Republic's peers are concerned, Roche Czech Republic posted net and EBITDA margin of 0.936% and 3.84%, respectively in 2015 and Amgen Czech Republic generated margins of 5.93% and 7.66%.